BioSpace News Archive

Drug Development

Aptinyx Presents Data on NMDA Receptor Modulator NYX-458 in a Preclinical Model of Parkinson’s Cognitive Impairment at the AAT-AD/PD Focus Meeting 2018

Aptinyx Inc. announced the presentation of preclinical data that supports advancing the development of a novel N-methyl D-aspartate (NMDA) receptor modulator, NYX-458, as a treatment for cognitive impairment associated with Parkinson’s disease.

March 15, 2018
·
2 min read
Genetown

Biogen to Present at the 2018 Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting

Data builds on Biogen’s core work in Alzheimer’s disease and movement disorders such as Parkinson’s disease and progressive supranuclear palsy; New aducanumab Phase 1b amyloid imaging analysis on the Centiloid scale; Biogen research programs target several of the identified causes of Alzheimer’s disease with an emphasis on early-stage disease

March 15, 2018
·
6 min read
Business

Proscia Inks Agreement to Bring Deep-Learning Technology to Dermatopathology

Landmark agreement positions Proscia to transform dermatopathology market − and opens doors to additional lab partnerships

March 15, 2018
·
4 min read
Business

MiMedx Announces Expectation to Exceed the $92 Million Top End of First Quarter Revenue Guidance

MiMedx Group, Inc. announced its expectation for first quarter of 2018 revenue to exceed the $92 million high end of its previously released guidance.

March 15, 2018
·
2 min read
Business

Medical Device Innovation Consortium (MDIC) Announces Pamela Goldberg, MBA Appointed as President and Chief Executive Officer (CEO)

Ms. Goldberg joins MDIC following her most recent tenure as an independent consultant

March 15, 2018
·
3 min read
BIOREM announces orders totalling $5.3 million

The orders are for air emission abatement projects in North America and Australia.

March 15, 2018
·
1 min read